SomaLogic to Present at the Stifel 2021 Virtual Healthcare Conference
Get Alerts SLGC Hot Sheet
Join SI Premium – FREE
NEW YORK and BOULDER, Colo., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Stifel 2021 Virtual Healthcare Conference.
SomaLogic’s management is scheduled to participate in a fireside chat on Wednesday, November 17, 2021 at 11:20 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.somalogic.com/events-and-presentations.
About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.
The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. Food and Drug Administration for diagnostic or patient management purposes.
SomaLogic Contact
Emilia Costales
720-798-5054
[email protected]
Investor Contact
Marissa Bych or Lynn Lewis
Gilmartin Group LLC
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Almost one in four people in England and Wales live in a legal aid desert
- Aastro Roofing Company Named Deerfield Beach's Roofer of the Year
- CORRECTION -- Carahsoft Strengthens Public Sector Cybersecurity Through Key Cybersecurity and Zero Trust Government Events in 2026
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stifel, Twitter, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share